生物
细胞生物学
干细胞
嵌合抗原受体
细胞
T细胞
免疫系统
造血
细胞毒性T细胞
细胞疗法
作者
Joey H. Li,Yvonne Y. Chen
出处
期刊:Cell Stem Cell
[Elsevier BV]
日期:2020-08-01
卷期号:27 (2): 192-194
被引量:17
标识
DOI:10.1016/j.stem.2020.07.010
摘要
Summary Senescence is a critical factor in several diseases, yet senolytic therapies targeting senescent cells remain hindered by lack of specificity. In the June issue of Nature, Amor et al. (2020) develop chimeric antigen receptor (CAR)-T cells targeting uPAR, a novel senescent-cell marker, to treat liver adenocarcinoma and liver fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI